Elanco CFO granted 8.7877 deferred stock units
Elanco’s EVP and CFO received a small deferred stock unit award that increases his long-term, share-linked compensation.
Rhea-AI Filing Summary
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that EVP and CFO Robert M. VanHimbergen received a grant of 8.7877 Deferred Stock Units on September 18, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent, generally settling after employment termination or in a specified future year. Following this award, he holds 158.6535 Deferred Stock Units directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units F1, F2 | 8.7877 | $22.42 | $197.02 |
Footnotes (2)
- F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Key Figures
Key Terms
Deferred Stock Units financial
cash equivalent financial
Executive Deferral and Stock Match Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ELAN report for EVP and CFO Robert M. VanHimbergen?
What do the Deferred Stock Units reported by ELAN represent?
When will the ELAN Deferred Stock Units for the CFO generally be settled?
What is the reported value per Deferred Stock Unit in the ELAN Form 4?
How many Deferred Stock Units in total does the ELAN CFO hold after this transaction?
Was the ELAN CFO’s Deferred Stock Unit grant made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.